Clinical Trial Update: Autologous Dendritic Cells and Allogenic Dendritic Secretomes for Patients With Advanced Nasopharyngeal Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/Phase 2 trial evaluating autologous dendritic cells and allogenic dendritic secretomes for advanced nasopharyngeal cancer; the study is active but not c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Cancer

Drugs mentioned

• Allogenic dendritic secretomes
• Autologous dendritic cells

Snippet

Sponsor: PT. Prodia Stem Cell Indonesia | Conditions: Nasopharyngeal Cancer | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING